Community research collaboration to develop a promotores-based hereditary breast cancer education program for Spanish-speaking Latinas.
Rebeca Almeida, Alejandra Lopez-Macha, Tania Dugatkin, Galen Joseph, Ysabel Duron, Alejandra Hurtado de Mendoza, Kristi D Graves, Laura Fejerman
Author Information
Rebeca Almeida: University of California, San Francisco, CA, USA. ORCID
Alejandra Lopez-Macha: University of California, San Francisco, CA, USA.
Tania Dugatkin: University of California, San Francisco, CA, USA.
Galen Joseph: University of California, San Francisco, CA, USA.
Ysabel Duron: The Latino Cancer Institute, San Jose, CA, USA.
Alejandra Hurtado de Mendoza: Georgetown University, Washington, DC, USA.
Kristi D Graves: Georgetown University, Washington, DC, USA.
Laura Fejerman: University of California, San Francisco, CA, USA.
中文译文
English
Breast cancer (BC) is the most common cancer in Latinas and the leading cause of cancer death. Latinas tend to be diagnosed at later stages, receive poorer quality care and have a higher risk of mortality than non-Latina White (NLW) women. Among women with a genetic predisposition to hereditary BC, genetic counseling can be beneficial. Latinas participate in genetic counseling at lower rates than NLW women. The goal of this study was to develop comprehensive, culturally appropriate materials for community health educators (promotores)-led hereditary BC education program for Spanish-speaking Latinas. We developed the curriculum through feedback from 7 focus groups, with a total of 68 participants (35 promotores and 33 community members). We used a mixed-methods approach that relied on quantitative analysis of survey questions and qualitative content analysis of the focus groups transcripts. Pre and post promotores' training survey responses suggested improvement in the promotores' cancer-related knowledge. Themes that emerged from the qualitative analyses were (i) barriers to health education and/or care; (ii) importance of educating the Latino community about BC and genetics and (iii) role of the promotores. Future research will further evaluate the impact of the program in promotores' knowledge and community members' screening behaviors.
J Genet Couns. 2011 Dec;20(6):625-38
[PMID: 21691939 ]
J Clin Oncol. 2007 Apr 10;25(11):1329-33
[PMID: 17416853 ]
Cancer. 2017 Feb 15;123(4):666-674
[PMID: 27787893 ]
Public Health Rev. 2016 Dec 7;37:31
[PMID: 29450072 ]
J Womens Health (Larchmt). 2012 May;21(5):557-66
[PMID: 22416791 ]
Breast Cancer Res Treat. 2011 Jun;127(3):729-38
[PMID: 21076864 ]
Nature. 1995 Dec 21-28;378(6559):789-92
[PMID: 8524414 ]
JAMA. 2015 Jan 13;313(2):165-73
[PMID: 25585328 ]
J Health Care Poor Underserved. 2006 May;17(2):256-64
[PMID: 16702713 ]
Genet Med. 2010 Feb;12(2):105-15
[PMID: 20061960 ]
Genet Med. 2011 Apr;13(4):349-55
[PMID: 21358336 ]
WMJ. 2009 Aug;108(5):259-62
[PMID: 19743759 ]
J Womens Health (Larchmt). 2010 Nov;19(11):2049-56
[PMID: 20849288 ]
J Psychosoc Oncol. 2006;24(3):19-52
[PMID: 17088240 ]
Health Educ Res. 2019 Aug 1;34(4):357-371
[PMID: 31121040 ]
Int J Environ Res Public Health. 2017 May 05;14(5):
[PMID: 28475137 ]
J Adv Nurs. 2014 Oct;70(10):2303-13
[PMID: 24628424 ]
Am J Prev Med. 2007 Nov;33(5):418-27
[PMID: 17950408 ]
J Community Health. 2019 Dec;44(6):1224-1252
[PMID: 31273620 ]
BMC Med Res Methodol. 2013 Sep 18;13:117
[PMID: 24047204 ]
J Oncol Pract. 2015 Jul;11(4):e460-7
[PMID: 26036266 ]
J Health Care Poor Underserved. 2016;27(2):568-79
[PMID: 27180696 ]
J Community Health. 2006 Feb;31(1):69-77
[PMID: 16482767 ]
J Genet Couns. 2010 Oct;19(5):447-62
[PMID: 20490636 ]
J Community Health. 2006 Aug;31(4):343-62
[PMID: 16894830 ]
J Genet Couns. 2006 Dec;15(6):505-14
[PMID: 17106633 ]
Oncol Nurs Forum. 1996 Sep;23(8):1305-12
[PMID: 8883075 ]
Genet Test. 2005 Summer;9(2):167-74
[PMID: 15943558 ]
Oncol Nurs Forum. 2015 Jan;42(1):15-22
[PMID: 25542317 ]
CA Cancer J Clin. 2017 Nov;67(6):439-448
[PMID: 28972651 ]
JAMA. 2010 Sep 1;304(9):967-75
[PMID: 20810374 ]
Am J Prev Med. 2017 Sep;53(3S1):S73-S77
[PMID: 28818249 ]
Int J Environ Res Public Health. 2019 Nov 29;16(23):
[PMID: 31795362 ]
Ann Surg Oncol. 2012 Jun;19(6):1732-7
[PMID: 22427173 ]
LDI Issue Brief. 2010 Oct-Nov;16(2):1-4
[PMID: 21545057 ]
Cancer Causes Control. 2011 Mar;22(3):367-74
[PMID: 21184267 ]
Genet Test Mol Biomarkers. 2010 Feb;14(1):99-106
[PMID: 19929403 ]
JAMA. 2012 Apr 18;307(15):1587-8
[PMID: 22511684 ]
J Womens Health (Larchmt). 2008 Jul-Aug;17(6):923-30
[PMID: 18554094 ]
Cancer. 2009 May 15;115(10):2222-33
[PMID: 19241424 ]
Rev Recent Clin Trials. 2014;9(4):245-53
[PMID: 25626062 ]
Health Educ Behav. 2009 Oct;36(5 Suppl):71S-90S
[PMID: 19805792 ]
J Genet Couns. 2020 Aug;29(4):505-517
[PMID: 31883202 ]
J Genet Couns. 2010 Jun;19(3):255-68
[PMID: 20151317 ]
J Community Health. 2011 Apr;36(2):219-27
[PMID: 20711645 ]
J Community Health. 2009 Feb;34(1):47-55
[PMID: 18821000 ]
J Genet Couns. 2010 Dec;19(6):618-29
[PMID: 20798982 ]
Prog Community Health Partnersh. 2008 Spring;2(1):55-60
[PMID: 20208190 ]
Science. 1994 Oct 7;266(5182):66-71
[PMID: 7545954 ]
Med Teach. 2013 Nov;35(11):e1561-72
[PMID: 24004029 ]
Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1666-72
[PMID: 26464428 ]
J Genet Couns. 2017 Dec;26(6):1221-1237
[PMID: 28374142 ]
Health Educ Behav. 2009 Oct;36(5 Suppl):91S-110S
[PMID: 19805793 ]
Science. 2003 Oct 24;302(5645):643-6
[PMID: 14576434 ]
Evid Rep Technol Assess (Full Rep). 2009 Jun;(181):1-144, A1-2, B1-14, passim
[PMID: 20804230 ]
J Health Dispar Res Pract. 2018;12(6):
[PMID: 34414017 ]
Health Educ Behav. 2002 Dec;29(6):755-70
[PMID: 12456132 ]
Am J Hum Genet. 2003 May;72(5):1117-30
[PMID: 12677558 ]
J Community Genet. 2020 Jan;11(1):85-99
[PMID: 31104207 ]
TL4 GM118986/NIGMS NIH HHS
UL1 TR001872/NCATS NIH HHS
Breast Neoplasms
Female
Health Education
Hispanic or Latino
Humans
Motivation
White People